SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice

Diabetes is a complex disease of increasingly common occurrence worldwide. Attaining optimal glycemic control is the main challenge to prevent the development of diabetes-related complications and/or to stop their progression. In recent years, the pharmacologic toolkit for the treatment of diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Spatola, Leonardo, Finazzi, Silvia, Angelini, Claudio, Dauriz, Marco, Badalamenti, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801228/
https://www.ncbi.nlm.nih.gov/pubmed/29177922
http://dx.doi.org/10.1007/s13300-017-0342-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801228/
https://www.ncbi.nlm.nih.gov/pubmed/29177922
http://dx.doi.org/10.1007/s13300-017-0342-8

Ejemplares similares